Global 3D Cell Culture Market Report 2020: An In-depth Analysis of Over 8,400 Patents, 2015-2020 - Forecast to 2030

News provided by

Jan 13, 2021, 13:30 ET

DUBLIN, Jan. 13, 2021 /PRNewswire/ -- The "3D Cell Culture Market by Scaffold Format, Products, Application Areas, Purpose, and Key Geographical Regions: Industry Trends and Global Forecasts (3rd Edition), 2020-2030" report has been added to ResearchAndMarkets.com's offering.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the 3D cell culture market. Based on multiple parameters, such as business segment, price of 3D cell culture products, and likely adoption of the 3D cell culture products, we have provided informed estimates on the likely evolution of the 3D cell culture systems market in the mid to long term.

An insightful assessment of the current market landscape of companies offering various 3D cell culture systems, along with information on a number of relevant parameters, such as year of establishment, size of employee base, geographical presence, 3D cell culture format (scaffold based products, scaffold free products and 3D bioreactors), and type of product (hydrogels / ECMs, micropatterned surfaces, solid scaffolds, microcarriers, attachment resistant surfaces, suspension systems and microfluidic systems). In addition, the chapter provides information related to the companies providing 3D culture related services, and associated reagents / consumables.

A detailed assessment of the overall landscape of scaffold based products, along with information on a number of relevant parameters, such as status of development (under development, developed not commercialized, and commercialized), type of product (hydrogels / ECMs, micropatterned surfaces, solid scaffolds, and microcarriers), source of 3D cultured cells (natural and synthetic), method used for fabrication (human based, animal based, plant based, and polymer based), and material used for fabrication. In addition, it presents details of the companies developing scaffold based products, highlighting year of establishment, size of employee base, and geographical presence.

A detailed assessment of the overall landscape of scaffold free products, along with information on a number of relevant parameters, such as status of development (under development, developed and not commercialized, and commercialized), type of product (attachment resistant surfaces, suspension systems and microfluidic systems), source of 3D cultured cells (natural and synthetic), method used for fabrication (human based, animal based, plant based and polymer based), and material used for fabrication. In addition, it presents details of the companies developing scaffold free products, highlighting their year of establishment, size of employee base, and geographical presence.

A detailed assessment of the overall landscape of 3D bioreactors, along with information on a number of relevant parameters, such as type of 3D bioreactor (single-use, perfusion, fed-batch, and fixed-bed), and typical working volume. In addition, it presents details of the companies developing 3D bioreactors, highlighting year of establishment, size of employee base, and geographical presence.
An insightful analysis, highlighting the applications (cancer research, drug discovery and toxicology, stem cell research, tissue engineering and regenerative medicine) for which various 3D cell culture products are being developed / used.

An in-depth analysis of over 8,400 patents that have been filed / granted for 3D cell culture products, between 2015 and 2020, highlighting key trends associated with these patents, across type of patent, publication year, issuing authorities involved, CPC symbols, emerging focus areas, leading patent assignees (in terms of number of patents filed / granted), patent characteristics and geography. It also includes a detailed patent valuation analysis.

An in-depth discussion on the classification of 3D cell culture systems, categorized as scaffold based systems (hydrogels / ECMs, solid scaffolds, micropatterned surfaces and microcarriers), scaffold free systems (attachment resistant surfaces, suspension systems and microfluidic systems) and 3D bioreactors.

An elaborate discussion on the methods used for fabrication of 3D matrices and scaffolds, highlighting the materials used, the process of fabrication, merits and demerits, and the applications of different fabrication methods.

Key Questions Answered

Who are the leading industry players engaged in the development of 3D cell culture products?
What are the most popular 3D cell culture products?
What are the different applications for which 3D cell culture products are currently being developed?
What are the key factors that are likely to influence the evolution of this market?
What is the trend of capital investments in the 3D cell culture systems market?
Which partnership models are commonly adopted by stakeholders in this industry?
How is the COVID-19 pandemic likely to impact the 3D cell culture systems market?
How is the current and future opportunity likely to be distributed across key market segments?
What are the anticipated future trends related to 3D cell culture systems market?

Companies Featured

101Bio
3D Biomatrix
3D Biotek
3D Biotechnology Solutions
3Dnamics
4Dcell
4titude
AbbVie Ventures
abc biopply
ABL Europe
Åbo Akademi University
Abstraction Ventures
Abzena
Accellta
Advanced BioMatrix
Advanced Regenerative Manufacturing Institute (ARMI)
Advanced Scientifics
Aetos Biologics
Afirmus Biosource
AGC
Agency for Science, Technology and Research (A*STAR)
AIM Biotech
Akero Therapeutics
Akron Biotech
Alector
Allevi
Alnylam Pharmaceuticals
American Laboratory Products
Alphabioregen
ALS Investment Fund
AlveoliX
AMS Biotechnology
AnaPath Services
Angel Investors
AngelMD
Angels 5K
Angels in MedCity
Angels Santé
Anthrogenesis
Aquitaine Science Transfert
Aquiti Gestion
AR Brown
ARL Design
ARTeSYN Biosolutions
AstraZeneca
Arizona State University
ATEL Ventures
Atera
Avantor
AxoSim
AXT
Axxicon
BASF
Bayer
B-CULTURE
BEOnChip
Bio-Byblos Biomedical
BioCat
BioConcept
BIOFABICS
Biogelx
Bioinspired Solutions
BioInvent International
BIOKÉ
BioLamina
Biomaterials USA
Biomerix
BiomimX
Biopredic International
BioTek Instruments
BiSS TGT
Bonus BioGroup
Bpifrance
BRAIN
BrainXell
Brammer Bio
Braveheart Investment Group
Bristol-Myers Squibb
Broad Institute
BRTI Life Sciences
Cambridge Bioscience
University of Cambridge
CarThera
Cedars-Sinai Medical Center
Celartia
Cell Applications
Cell Culture
CELLEC BIOTEK
Cellendes
Cellevate
CELLnTEC
CellSpring
CellSystems
CelVivo
Center for the Advancement of Science in Space
CESCO Bioengineering
Charles River Laboratories
Cherry Biotech
China Regenerative Medicine International
CITIC Securities
CN Bio Innovations
CN Innovations
Collagen Solutions
Comune di Milano
Corning Life Sciences
Cosmo Bio
CELLphenomics
Commonwealth Serum Laboratories
Curi Bio
Cyprio
Cyprotex
Cytiva
Danaher
Deepbridge Capital
Demcon
United States Department of Defense
Development Bank of Wales
DiPole Materials
Downing Ventures
Government of the Netherlands
Executive Agency for Small and Medium-sized Enterprises (EASME)
EBERS
Ectica Technologies
EDITHGEN
Electrospinning
Emulate
Enso Discoveries
Eppendorf
Esco Aster
Esperante
Ethicon
European Life Sciences Growth Fund (ELSGF)
European Commission
European Union
Eurostars
EU-ToxRisk
Eva Scientific
Evotec
faCellitate
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Fennik Life Sciences
Ferentis
FHNW University
FiberCell Systems
Fibralign
Finep
Finesse Solutions
Finovam Gestion
Flexcell International
Foundation for Technological Innovation
Founder
Founders Fund
Freeline
French Government
Frequency Therapeutics
FroggaBio
Fujifilm
FUJIFILM Wako Pure Chemical
Funakoshi
Gabriel Investments
Galapagos
GALIA Gestion
Gamma 3
Gelmetix
Gelomics
Gemini Bio
Gemstone Biotherapeutics
Genome Institute of Singapore
Georgia Research Alliance
Global Cell Solutions
Government of China
Great Stuff Ventures
GSI
GlaxoSmithKline
HµREL
Hamilton
Harvard Apparatus
Harvard College
HCS Pharma
Helvoet
Heraeus Medical
Hesperos
Histogenics
Human Models for Analysis of Pathways (HMAPs) Center
Hokkaido Soda
HP Wild Holding
Hubrecht Organoid Technology
Humanetics
Hyamedix
ibidi
IMSS-Gulf Bio Analytical
INITIO CELL
Innovate UK
Innovation Fund Denmark
Inova Health System
inRegen
InSphero
Invitrocue
InvivoSciences
Ionis Pharmaceuticals
Irdi Soridec Gestion
Janssen Biotech
Japan Vilene Company
Jellagen Marine Biotechnologies
Johns Hopkins University
JRI Orthopaedics
Kero
Kim & Friends
Kirkstall
KIYATEC
KOKEN
Koninklijke Nederlandse Akademie Van Wetenschappen
Kuraray
LabCorp
Laconia
LAMBDA Laboratory Instruments
Lantern Pharma
Lawrence J. Ellison Institute for Transformative Medicine
LBA Healthcare Management
Lena Biosciences
LFB Biomanufacturing
Life Technologies
Lifecore Biomedical
LifeNet Health
Laboratory for Integrated Micro Mechatronic Systems
Lineage Cell Therapeutics
Locate Bio
London School of Hygiene & Tropical Medicine
Lonza
Lund University
LuoLabs
Manchester BIOGEL
University of Mannheim
Maryland Momentum Fund
Massachusetts Institute of Technology
MassChallenge
MatTek Life Sciences
MBL International
GlassWall Syndicate
Menicon Life Science
Merck Accelerator
Merck Millipore
Michael J. Fox Foundation
Michigan Technological University
Micronit
MicroTissues
Midven
MIMETAS
Minerva Business Angel Network
Molecular Devices
Maryland Stem Cell Research Fund (MSCRF)
MTTlab
Nanobiose
Nano Dimension
Nanofiber Solutions
Nanogaia
National Aeronautics and Space Administration
National Center for Advancing Translational Sciences
National Institute of Health
National Institute on Aging
National Institutes for Food and Drug Control
National Science Foundation
National University Hospital
National University of Singapore
National Centre for the Replacement, Refinement and Reduction of Animals in Research
Neuromics
New Orleans BioFund
Newable Private Investing
Nexcelom Bioscience
Nord France Amorquage
Invest Northern Ireland
Northwick Park Institute for Medical Research
Nortis
Nova Biomedical
Novartis Venture Fund
Noviocell
Nucleus Biologics
NYU Winthrop Hospital
Olaregen Therapeutix
OMNI Life Science
Oregon Health & Science University
Organovo
Orthomimetics
OS Fund
Oxford MEStar
Pairnomix
Pall Corporation
Path BioAnalytics
PBS Biotech
Peak Capital Advisors
Pelo Biotech
Pensees
PepGel
Percell Biolytica
PerkinElmer
Pfizer
PHI
Pitch@Palace
PL BioScience
Plasticell
Pluristem Therapeutics
Portugal Ventures
Precision Biologics
Premedical Laboratories
Primorigen Biosciences
Principia SGR
ProBio
ProBioGen
Prodizen
PromoCell
Protista International
QGel Bio
QIAGEN (Suzhou)
Quintech Life Sciences
PT Rajawali Medika Mandiri
RASA
React4life
Real Research
RealBio Technology
Regemat3D
Repligen
REPROCELL
Research Without Animal Experiment
Revivocell
Rigenerand
Roche
RoosterBio
Roswell Park Comprehensive Cancer Center
Sanofi Ventures
SARSTEDT
Sartorius
S-BIO
ScienCell
SciFi VC
SciKon Innovation
Scinus Cell Expansion
Scottish Investment Bank
Seres Therapeutics
Shanghai Cienle Medical Technology
Shanghai Institute of Materia Medica
Shanghai Institute of Biochemistry and Cell Biology
Siemens Technology
Sigma-Aldrich
SKE Research Equipment
SmiLe Incubator
SoloHill Engineering
Spheritech
Spiber Technologies
Start-Up Chile
State Key Laboratory of Experimental Hematology
StemCell Systems
STEMCELL Technologies
Stemmatters
StemoniX
StemTek Therapeutics
SUN bioscience
Commission for Technology and Innovation
Swiss Federal Laboratories for Materials Science and Technology
SyndicateRoom
Synthecon
SynVivo
TA Instruments
Takeda
Tantti Laboratory
tebu-bio
TEDCO
Terumo
Texas Tech University Health Sciences Center
Development Bank of Wales
Ministry of Higher Education, Research and Innovation (France)
The Idea Village
Institute for Molecular Medicine Finland
Mario Negri Institute for Pharmacological Research
University of Alberta
University of Bath
University of Brescia
University of Bristol
University of Manchester
University of Milan
University of Strathclyde
University of Zurich
TheWell Bioscience
Thermo Fisher Scientific
Tianjin Weikai Biological Engineering
Tissue Click
TissueLabs
TissUse
Tokyo Future Style
TPG
TreeFrog Therapeutics
Trevigen
Triumvirate Environmental
Technical University of Berlin
Twinhelix
UK Innovation & Science Seed Fund
Science and Technology Facilities Council (STFC)
UK Science and Technology Facilities Council
University of Genoa
University College London
University Hospital Zurich
Stanford University
University of Arkansas for Medical Sciences
University of California
University of Central Florida
University of Nottingham
The University of Sheffield
University of Washington School of Pharmacy
University of Zurich
UPM Biomedicals
U.S. Small Business Administration
UW Medicine
VA Portland Health Care System
Vanderbilt University
Venture Kick
VentureSouth
Venturecraft
Viscofan BioEngineering
Visikol
Vivo Biosciences
VWR
Wake Forest Institute for Regenerative Medicine
Women Who Tech
XAnge
Xenos
XP Biomed
Xylyx Bio
Zhejiang University
zPREDICTA

For more information about this report visit https://www.researchandmarkets.com/r/jpy37n

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets